Advertisement

Metabolic Activation and DNA Adducts of Aromatic Amines and Nitroaromatic Hydrocarbons

  • F. A. Beland
  • F. F. Kadlubar
Part of the Handbook of Experimental Pharmacology book series (HEP, volume 94 / 1)

Abstract

The commercial production of aromatic amines and nitroaromatic hydrocarbons began in the middle 1800s following the synthesis of aniline and the aniline-based dyes, rosaniline and mauve. Thirty years later, Rehn (1895) noted an increased incidence of urinary bladder cancer in German dyestuff workers, which Leichtenstern (1898) suggested could be due to their exposure to naphthylamines. This initial report was rapidly followed by additional epidemiological studies until it became incontrovertible that exposure to 2-naphthylamine, benzidine, and 4-aminobiphenyl could lead to the induction of bladder cancer in humans (reviewed in Parkes and Evans 1984).

Keywords

Chinese Hamster Ovary Cell Aromatic Amine Mutagenic Response Heterocyclic Aromatic Amine Major Adduct 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Allaben WT, Weeks CE, Weis CC, Burger GT, King CM (1982) Rat mammary gland carcinogenesis after local injection of TV-hydroxy-N-acyl-2-aminofluorenes: relationship to metabolic activation. Carcinogenesis 3: 233–240.PubMedGoogle Scholar
  2. Allaben WT, Weis CC, Fullerton NF, Beland FA (1983) Formation and persistence of DNA adducts from the carcinogen N-hydroxy-2-acetylaminofluorene in rat mammary gland in vivo. Carcinogenesis 4: 1067–1070.PubMedGoogle Scholar
  3. Andersen RA, Enomoto M, Miller EC, Miller J A (1964) Carcinogenesis and inhibition of the Walker 256 tumor in the rat by /r/w-4-acetylaminostilbene, its 7V-hydroxy metabolite, and related compounds. Cancer Res 24: 128–143.PubMedGoogle Scholar
  4. Andervont HB, Edwards JE (1943) Carcinogenic action of two azo compounds in mice. JNCI 3: 349–354.Google Scholar
  5. Andrews PJ, Quilliam MA, McCarry BE, Bryant DW, McCalla DR (1986) Identification of the DNA adduct formed by metabolism of 1,8-dinitropyrene in Salmonella typhimurium. Carcinogenesis 7: 105–110.PubMedGoogle Scholar
  6. Arce GT, Cline DT Jr, Mead JE (1987) The 32P-post-labeling method in quantitative DNA adduct dosimetry of 2-acetylaminofluorene-induced mutagenicity in Chinese hamster ovary cells and Salmonella typhimurium TA1538. Carcinogenesis 8: 515–520.PubMedGoogle Scholar
  7. Baldwin RW, Smith WRD (1965) JV-Hydroxylation in aminostilbene carcinogenesis. Br J Cancer 19: 433–443.PubMedGoogle Scholar
  8. Baldwin RW, Smith WRD, Surtees SJ (1963) Carcinogenic action of 7V-hydroxy-4-acetylaminostilbene. Nature 199: 613–614.PubMedGoogle Scholar
  9. Ball LM, King LC (1985) Metabolism, mutagenicity, and activation of 1-nitropyrene in vivo and in vitro. Environ Int 11: 355–362.Google Scholar
  10. Ball LM, Kohan MJ, Claxton LD, Lewtas J (1984 a) Mutagenicity of derivatives and metabolites of 1-nitropyrene: activation by rat liver S9 and bacterial enzymes. Mutat Res 138: 113–125.Google Scholar
  11. Ball LM, Kohan MJ, Inmon JP, Claxton LD, Lewtas J (1984 b) Metabolism of 1- nitro[14C]pyrene in vivo in the rat and mutagenicity of urinary metabolites. Carcinogenesis 5: 1557–1564.Google Scholar
  12. Baur H, Neumann H-G (1980) Correlation of nucleic acid binding by metabolites of trans- 4-aminostilbene derivatives with tissue specific acute toxicity and carcinogenicity in rats. Carcinogenesis 1: 877–885.PubMedGoogle Scholar
  13. Beland FA (1978) Computer-generated graphic models of the N2-substituted deoxy- guanosine adducts of 2-acetylaminofluorene and benzo[a]pyrene and the (N2-substituted deoxyguanosine adduct of 1-naphthylamine in the DNA double helix. Chem Biol Interact 22: 329–339PubMedGoogle Scholar
  14. Beland FA, Kadlubar FF (1985) Formation and persistence of arylamine DNA adducts in vivo. Environ Health Perspect 62: 19–30.PubMedGoogle Scholar
  15. Beland FA, Dooley KL, Casciano DA (1979) Rapid isolation of carcinogen-bound DNA and RNA by hydroxyapatite chromatography. J Chromatogr 174: 177–186.PubMedGoogle Scholar
  16. Beland FA, Allaben WT, Evans FE (1980 a) Acyltransferase-mediated binding of N-hydroxyarylamides to nucleic acids. Cancer Res 40: 834–840.Google Scholar
  17. Beland FA, Tullis DL, Kadlubar FF, Straub KM, Evans FE (1980 b) Characterization of DNA adducts of the carcinogen N-methyl-4-aminoazobenzene in vitro and in vivo. Chem Biol Interact 31: 1–17.Google Scholar
  18. Beland FA, Dooley KL, Jackson CD (1982) Persistence of DNA adducts in rat liver and kidney after multiple doses of the carcinogen N-hydroxy-2-acetylaminofluorene. Cancer Res 42: 1348–1354.PubMedGoogle Scholar
  19. Beland FA, Beranek DT, Dooley KL, Heflich RH, Kadlubar FF (1983) Arylamine-DNA adducts in vitro and in vivo: their role in bacterial mutagenesis and urinary bladder carcinogenesis. Environ Health Perspect 49: 125–134.PubMedGoogle Scholar
  20. Beland FA, Ribovich M, Howard PC, Heflich RH, Kurian P, Milo GE (1986) Cytotoxicity, cellular transformation and DNA adducts in normal human diploid fibroblasts exposed to 1-nitrosopyrene, a reduced derivative of the environmental contaminant, 1-nitropyrene. Carcinogenesis 7: 1279–1283.PubMedGoogle Scholar
  21. Belman S, Troll W, Teebor G, Mukai F (1968) The carcinogenic and mutagenic properties of N-hydroxy-aminonaphthalenes. Cancer Res 28: 535–542.PubMedGoogle Scholar
  22. Beranek DT, White GL, Heflich RH, Beland FA (1982) Aminofluorene-DNA adduct formation in Salmonella typhimurium exposed to the carcinogen N-hydroxy-2- acetylaminofluorene. Proc Natl Acad Sci USA 79: 5175–5178.PubMedGoogle Scholar
  23. Bichara M, Fuchs RPP (1985) DNA binding and mutation spectra of the carcinogen N-2- aminofluorene in Escherichia coli. A correlation between the conformation of the premutagenic lesion and the mutation specificity. J Mol Biol 183: 341–351.Google Scholar
  24. Bichara M, Fuchs RPP (1988) The uvrC gene product has no specific role in the repair of iV-2-aminofluorene adducts. In: King CM, Romano LJ, Schuetzle D (eds) Carcinogenic and mutagenic responses to aromatic amines and nitroarenes. Elsevier, New York, pp 385–387.Google Scholar
  25. Boiteux S, de Oliveira RC, Laval J (1985) The Escherichia coli 06-methylguanine-DNA methyltransferase does not repair promutagenic 06-methylguanine residues when present in Z-DNA. J Biol Chem 260: 8711–8715.Google Scholar
  26. Boyd J A, Eling TE (1984) Evidence for a one-electron mechanism of 2-aminofluorene oxidation by prostaglandin H synthase and horseradish peroxidase. J Biol Chem 259: 13885–13896.PubMedGoogle Scholar
  27. Boyd JA, Eling TE (1987) Prostaglandin H synthase-catalyzed metabolism and DNA binding of 2-naphthylamine. Cancer Res 47: 4007–4014.PubMedGoogle Scholar
  28. Boyd J A, Harvan DJ, Eling TE (1983) The oxidation of 2-aminofluorene by prostaglandin endoperoxide synthetase. Comparison with other peroxidases. J Biol Chem 258: 8246-8254Google Scholar
  29. Brookman KW, Salazar EP, Thompson LH (1985) Comparative mutagenic efficiencies of the DNA adducts from the cooked-food-related mutagens Trp-P-2 and IQ in CHO cells. Mutation Res 149: 249–255.PubMedGoogle Scholar
  30. Broyde S, Hingerty BE (1982) DNA backbone conformation in AAF modified dCpdG: variable conformational modes of achieving base displacement. Chem Biol Interact 40: 113–119.PubMedGoogle Scholar
  31. Broyde S, Hingerty B (1983) Conformation of 2-aminofluorene-modifled DNA. Biopolymers 22: 2423–2441.PubMedGoogle Scholar
  32. Broyde S, Hingerty B (1985) Base displacement in AAF-modified Z-DNA. Carcinogenesis 6: 151–154.PubMedGoogle Scholar
  33. Bruce WR (1987) Recent hypotheses for the origin of colon cancer. Cancer Res 47: 4237–4242.PubMedGoogle Scholar
  34. Bryant DW, McCalla DR, Lultschik P, Quilliam MA, McCarry BE (1984) Metabolism of 1,8-dinitropyrene by Salmonella typhimurium. Chem Biol Interact 49: 351–368.PubMedGoogle Scholar
  35. Bryant MS, Skipper PL, Tannenbaum SR, Maclure M (1987) Hemoglobin adducts of 4-aminobiphenyl in smokers and nonsmokers. Cancer Res 47: 602–608.PubMedGoogle Scholar
  36. Busby WF Jr, Garner RC, Chow FL, Martin CN, Stevens EK, Newberne PM, Wogan GN (1985) 6-Nitrochrysene is a potent tumorigen in newborn mice. Carcinogenesis 6: 801–803.Google Scholar
  37. Busby WF Jr, Stevens EK, Kellenbach ER, Cornelisse J, Lugtenburg J (1988) Dose- response relationships of the tumorigenicity of cyclopenta[cd]pyrene, benzo[a]pyrene and 6-nitrochrysene in a newborn mouse lung adenoma bioassay. Carcinogenesis 9: 741–746.PubMedGoogle Scholar
  38. Buu-Hoi NP, Bui-Quoc-Huong, Tran-lu-Y, (1962a) Activité chimiothérapeutique du 6-aminochrysène dans les splénomégalies. Bull Acad Natl Med (Paris) 146: 313–317.Google Scholar
  39. Buu-Hoi NP, Bui-Quoc-Huong, Tran-lu-Y, Chau-Van-Tuong (1962 b) Résultats préliminaires d’une tentative de chimiothérapie spécifique au moyen du 6- aminochryséne. Chemotherapia (Basel) 4: 31–42.Google Scholar
  40. Buu-Hoi NP, Bui-Quoc-Huong, Tran-lu-Y (1962 c) Action leucopéniante du 6- aminochryséne dans les leucémies myeloides chez l’homme. Chemotherapia (Basel) 4: 413–418.Google Scholar
  41. Carothers AM, Urlaub G, Steigerwalt RW, Chasin LA, Grunberger D (1988) Spectrum of N-2-acetylaminofluorene-induced mutations in the dihydrofolate reductase gene of Chinese hamster ovary cells. In: King CM, Romano LJ, Schuetzle D (eds) Carcinogenic and mutagenic responses to aromatic amines and nitroarenes. Elsevier, New York, pp 337–349.Google Scholar
  42. Cerniglia CE, Lambert KJ, White GL, Heflich RH, Franklin W, Fifer EK, Beland FA (1988) Metabolism of 1,8-dinitropyrene by human, rhesus monkey, and rat intestinal microflora. Toxicity Assessment: An International Journal 3: 147–159.Google Scholar
  43. Cilento G, Miller EC, Miller J A (1956) On the addition of protons to derivatives of 4-aminoazobenzene. J Am Chem Soc 78: 1718–1722.Google Scholar
  44. Coles B, Ketterer B, Beland FA, Kadlubar FF (1984) Glutathione conjugate formation in the detoxification of ultimate and proximate carcinogens of N-methyl-4- aminoazobenzene. Carcinogenesis 5: 917–920.PubMedGoogle Scholar
  45. Conney AH (1982) Induction of microsomal enzymes by foreign chemicals and carcinogenesis by poly cyclic aromatic hydrocarbons: G.H.A. Clowes Memorial Lecture. Cancer Res 42: 4875–4917.PubMedGoogle Scholar
  46. Daune MP, Westhof E, Koffel-Schwartz N, Fuchs RPP (1985) Covalent binding of a carcinogen as a probe for the dynamics of deoxyribonucleic acid. Biochemistry 24: 2275–2284.PubMedGoogle Scholar
  47. DeBaun JR, Miller EC, Miller J A (1970) N-Hydroxy-2-acetylaminofluorene sulfotrans- ferase: its probable role in carcinogenesis and in protein-(methion-(S-yl) binding in rat liver. Cancer Res 30: 577–595.Google Scholar
  48. Deichmann WB, Radomski JL (1969) Carcinogenicity and metabolism of aromatic amines in the dog. JNCI 43: 263–269.Google Scholar
  49. Deichmann WB, MacDonald WM, Coplan MM, Woods FM, Anderson WAD (1958 a) Para nitrobiphenyl, a new bladder carcinogen in the dog. Ind Med Surg 27: 634–637.Google Scholar
  50. Deichmann WB, Radomski JL, Anderson WAD, Coplan MM, Woods FM (1958 b) The carcinogenic action of aminobiphenyl in the dog. Ind Med Surg 27: 25–26.Google Scholar
  51. Delclos KB, Tarpley WG, Miller EC, Miller JA (1984) 4-Aminoazobenzene and N,N- dimethyl-4-aminoazobenzene as equipotent hepatic carcinogens in male C57BL/6 x C3H/He Ft mice and characterization of 8-(deoxyguanosin-8-yl)-4-aminoazobenzene as the major persistent hepatic DNA-bound dye in these mice. Cancer Res 44: 2540–2550.Google Scholar
  52. Delclos KB, Miller EC, Miller JA, Liem A (1986) Sulfuric acid esters as major ultimate electrophilic and hepatocarcinogenic metabolites of 4-aminoazobenzene and its TV-methyl derivatives in infant male C57BL/6J x C3H/HeJ Fj (B6C3FJ mice. Car-cinogenesis 7: 277 - 287Google Scholar
  53. Delclos KB, Miller DW, Lay JO Jr, Casciano DA, Walker RP, Fu PP, Kadlubar FF (1987 a) Identification of C8-modifIed deoxyinosine and N2- and C8-modified deoxyguanosine as major products of the in vitro reaction of iV-hydroxy-6- aminochrysene with DNA and the formation of these adducts in isolated rat hepatocytes treated with 6-nitrochrysene and 6-aminochrysene. Carcinogenesis 8: 1703–1709.Google Scholar
  54. Delclos KB, Walker RP, Dooley KL, Fu PP, Kadlubar FF (1987 b) Carcinogen-DNA ad- duct formation in the lungs and livers of preweanling CD-I male mice following ad-ministration of [3H]-6-nitrochrysene, [3H]-6-aminochrysene, and [3H]-l,6-dinitro- pyrene. Cancer Res 47: 6272–6277.Google Scholar
  55. DiPaolo JA, DeMarinis AJ, Chow FL, Garner RC, Martin CN, Doniger J (1983) Nitration of carcinogenic and non-carcinogenic polycyclic aromatic hydrocarbons results in products able to induce transformation of Syrian hamster cells. Carcinogenesis 4: 357–359.PubMedGoogle Scholar
  56. Djuric Z, Fifer EK, Beland FA (1985) Acetyl coenzyme A-dependent binding of carcinogenic and mutagenic dinitropyrenes to DNA. Carcinogenesis 6: 941–944.PubMedGoogle Scholar
  57. Djuric Z, Fifer EK, Howard PC, Beland FA (1986 a) Oxidative microsomal metabolism of 1-nitropyrene and DNA-binding of oxidized metabolites following nitroreduction. Carcinogenesis 7: 1073–1079.Google Scholar
  58. Djuric Z, Heflich RH, Fifer EK, Beland FA ( 1986 b) Metabolic activation of mutagenic and tumorigenic dinitropyrenes. In: Harris C (ed) Biochemical and molecular epidemiology of cancer. Liss, New York, pp 441–447.Google Scholar
  59. Djuric Z, Potter DW, Heflich RH, Beland FA (1986 c) Aerobic and anaerobic reduction of nitrated pyrenes in vitro. Chem Biol Interact 59: 309–324.Google Scholar
  60. Djuric Z, Fifer EK, Yamazoe Y, Beland FA (1988) DNA binding by 1-nitropyrene and 1,6-dinitropyrene in vitro and in vivo: effects of nitroreductase induction. Carcinogenesis 9: 357–364.PubMedGoogle Scholar
  61. Dooley KL, Beland FA, Bucci TJ, Kadlubar FF (1984) Local carcinogenicity, rates of ab-sorption, extent and persistence of macromolecular binding, and acute histopathological effects of N-hydroxy-1-naphthylamine and iV-hydroxy-2-naphthylamine. Cancer Res 44: 1172–1177.PubMedGoogle Scholar
  62. El-Bayoumy K, Hecht SS (1983) Identification and mutagenicity of metabolites of 1-nitropyrene formed by rat liver. Cancer Res 43: 3132–3137.PubMedGoogle Scholar
  63. El-Bayoumy K, Hecht SS (1984) Metabolism of l-nitro[C/-4,5,9,10-14C]pyrene in the F344 rat. Cancer Res 44: 4317–4322.PubMedGoogle Scholar
  64. El-Bayoumy K, Hecht SS, Hoffmann D (1982) Comparative tumor initiating activity on mouse skin of 6-nitrobenzo[a]pyrene, 6-nitrochrysene, 3-nitroperylene, 1-nitropyrene and their parent hydrocarbons. Cancer Lett 16: 333–337.PubMedGoogle Scholar
  65. El-Bayoumy K, Hecht SS, Sackl T, Stoner GD (1984) Tumorigenicity and metabolism of 1-nitropyrene in A/J mice. Carcinogenesis 5: 1449–1452.PubMedGoogle Scholar
  66. Eling TE, Petry TW, Hughes MF, Krauss RS (1988) Aromatic amine metabolism catalyzed by prostaglandin H synthase. In: King CM, Romano LJ, Schuetzle D (eds) Carcinogenic and mutagenic responses to aromatic amines and nitroarenes. Elsevier, New York, pp 161–172.Google Scholar
  67. Evans FE, Miller DW (1982) Conformation and dynamics associated with the site of attachment of a carcinogen to a nucleotide. Biochem Biophys Res Commun 108: 933–939.PubMedGoogle Scholar
  68. Evans FE, Miller DW, Beland FA (1980) Sensitivity of the conformation of de- oxyguanosine to binding at the C-8 position by JV-acetylated and unacetylated 2- aminofluorene. Carcinogenesis 1: 955–959.PubMedGoogle Scholar
  69. Feiton JS, Knize MG, Shen NH, Wu R, Becher G (1988) Mutagenic heterocyclic im- idazoamines in cooked foods. In: King CM, Romano LJ, Schuetzle D (eds) Carcinogenic and mutagenic responses to aromatic amines and nitroarenes. Elsevier, New York, pp 73–85.Google Scholar
  70. Fifer EK, Howard PC, Heflich RH, Beland FA (1986) Synthesis and mutagenicity of 1- nitropyrene 4,5-oxide and 1-nitropyrene 9,10-oxide, microsomal metabolites of 1- nitropyrene. Mutagenesis 1: 433–438.PubMedGoogle Scholar
  71. Flammang TJ, Kadlubar FF (1986) Acetyl coenzyme A-dependent metabolic activation of Ar-hydroxy-3,2’-dimethyl-4-aminobiphenyl and several carcinogenic N-hydroxy arylamines in relation to tissue and species differences, other acyl donors, and aryl- hydroxamic acid-dependent acyltransferases. Carcinogenesis 7: 919–926.PubMedGoogle Scholar
  72. Flammang TJ, Westra JG, Kadlubar FF, Beland FA (1985) DNA adducts formed from the probable proximate carcinogen, Af-hydroxy-3,2’-dimethyl-4-aminobiphenyl, by acid catalysis or S-acetyl coenzyme A-dependent enzymatic esterification. Carcinogenesis 6: 251–258.PubMedGoogle Scholar
  73. Flammang TJ, Hein DW, Talaska G, Kadlubar FF (1988) iV-Hydroxy-arylamine O- acetyltransferase and its relationship to aromatic amine N-acetyltransferase polymorphism in the inbred hamster and in human tissue cytosol. In: King CM, Romano LJ, Schuetzle D (eds) Carcinogenic and mutagenic responses to aromatic amines and nitroarenes. Elsevier, New York, pp 137–148.Google Scholar
  74. Fourney RM, O’Brien PJ, Davidson WS (1986) Peroxidase catalyzed aggregation of plas-mid pBR322 DNA by benzidine metabolites in vitro. Carcinogenesis 7: 1535–1542.PubMedGoogle Scholar
  75. Franz R, Neumann H-G (1987) Reaction of Zra 4-4-N-acetoxy-N-acetylaminostilbene with guanosine, deoxyguanosine, RNA and DNA in vitro: predominant product is a cyclic tV2,7V3-guanine adduct. Chem Biol Interact 62: 143–155.PubMedGoogle Scholar
  76. Frederick CB, Beland FA (1988) Comparison of the metabolism, biological activity, and chemical reactivity of 1-naphthylamine and 2-naphthylamine. In: Yang SK, Silverman BD (eds) Poly cyclic aromatic hydrocarbon carcinogenesis: structure-activity relationships, vol II. CRC Press, Boca Raton, pp 111–139.Google Scholar
  77. Frederick CB, Mays JB, Ziegler DM, Guengerich FP, Kadlubar FF (1982) Cytochrome P- 450- and flavin-containing monooxygenase-catalyzed formation of the carcinogen N- hydroxy-2-aminofluorene and its covalent binding to nuclear DNA. Cancer Res 42: 2671–2677.PubMedGoogle Scholar
  78. Frederick CB, Weis CC, Flammang TJ, Martin CN, Kadlubar FF (1985) Hepatic N- oxidation, acetyl-transfer and DNA-binding of the acetylated metabolites of the car-cinogen, benzidine. Carcinogenesis 6: 959–965.PubMedGoogle Scholar
  79. Fuchs RPP (1975) In vitro recognition of carcinogen-induced local denaturation sites in native DNA by Sx endonuclease from Aspergillus oryzae. Nature 257: 151–152.PubMedGoogle Scholar
  80. Fuchs R, Daune M (1972) Physical studies on deoxyribonucleic acid after covalent binding of a carcinogen. Biochemistry 11: 2659–2666.PubMedGoogle Scholar
  81. Fuchs RPP, Daune MP (1974) Dynamic structure of DNA modified with the carcinogen Af-aeetoxy-N-2-acetylaminofluorene. Biochemistry 13:4435 4440 Fuchs RPP, Lefevre J-F, Pouyet J, Daune MP (1976) Comparative orientation of the fluorene residue in native DNA modified by JV-acetoxy-N-2-acetylaminofluorene and two 7-halogeno derivatives. Biochemistry 15: 3347–3351.Google Scholar
  82. Fuchs RPP, Bichara M, Koffel-Schwartz N (1988) Molecular mechanisms involved in mutagenesis induced by N-2-aminofluorene derivatives. In: King CM, Romano LJ, Schuetzle D (eds) Carcinogenic and mutagenic responses to aromatic amines and nitroarenes. Elsevier, New York, pp 373–384.Google Scholar
  83. Fujii K (1983) Induction of tumors in transplacental or neonatal mice administered 3’-methyl-4-dimethylaminoazobenzene or 4-aminoazobenzene. Cancer Lett 17: 321–325.PubMedGoogle Scholar
  84. Fujita J, Srivastava SK, Kraus MH, Rhim JS, Tronick SR, Aaronson SA (1985) Frequency of molecular alterations affecting ras protooncogenes in human urinary tract tumors. Proc Natl Acad Sci USA 82: 3849–3853.PubMedGoogle Scholar
  85. Gallagher JE, Robertson IGC, Jackson MA, Dietrich AM, Ball LM, Lewtas J (1988) 32P- Postlabeling analysis of DNA adducts of two nitrated polycyclic aromatic hydrocarbons in rabbit tracheal epithelial cells. In: King CM, Romano LJ, Schuetzle D (eds) Carcinogenic and mutagenic responses to aromatic amines and nitroarenes. Elsevier, New York, pp 277–281.Google Scholar
  86. Garner RC, Martin CN, Clayson DB (1984) Carcinogenic aromatic amines and related compounds. In: Searle CE (ed) Chemical carcinogens, vol 1. American Chemical Society, Washington DC, pp 175–276.Google Scholar
  87. (ACS Monograph 182).
    Garner RC, Stanton CA, Martin CN, Chow FL, Thomas W, Hubner D, Herrmann R (1986) Bacterial mutagenicity and chemical analysis of polycyclic aromatic hydrocarbons and some nitro derivatives in environmental samples collected in West Germany. Environ Mutagen 8: 109–117.PubMedGoogle Scholar
  88. Gaugier BJM, Neumann H-G (1979) The binding of metabolites formed from aminostilbene derivatives to nucleic acids in the liver of rats. Chem Biol Interact 24: 355–372.Google Scholar
  89. Gaugler BJM, Neumann H-G, Scribner NK, Seribner JD (1979) Identification of some products from the reaction of raw-4-aminostilbene metabolites and nucleic acids in vivo. Chem Biol Interact 27: 335–342.PubMedGoogle Scholar
  90. Green LC, Skipper PL, Turesky RJ, Bryant MS, Tannenbaum SR (1984) In vivo dosimetry of 4-aminobiphenyl in rats via a cysteine adduct in hemoglobin. Cancer Res 44: 4254–4259.PubMedGoogle Scholar
  91. Groupe Européen du Cancer du Sein (1967) Induction par le 6-aminochryséne de rémission du cancer du sein en phase avancée chez la femme. Eur J Cancer 3: 75–77.Google Scholar
  92. Grunberger D, Nelson JH, Cantor CR, Weinstein IB (1970) Coding and conformational properties of oligonucleotides modified with the carcinogen N-2-acetylaminofluorene. Proc Natl Acad Sci USA 66: 488–494.PubMedGoogle Scholar
  93. Gupta RC, Dighe NR (1984) Formation and removal of DNA adducts in rat liver treated with N-hydroxy derivatives of 2-acetylaminofiuorene, 4-acetylaminobiphenyl, and 2- acetylaminophenanthrene. Carcinogenesis 5: 343–349.PubMedGoogle Scholar
  94. Gupta RC, Earley K (1988) 32P-adduct assay: comparative recoveries of structurally diverse DNA adducts in the various enhancement procedures. Carcinogenesis 9: 1687–1693.Google Scholar
  95. Gupta RC, Earley K, Fullerton NF, Beland FA (1985) Formation and removal of DNA adducts in rats administered multiple doses of 2-acetylaminophenanthrene. Proc Am Assoc Cancer Res 26:86 Gupta RC, Earley K, Fullerton NF, Beland FA (1986) Formation and removal of DNA adducts in target and nontarget tissues of female rats administered multiple doses of 2- acetylaminophenanthrene. Proc Am Assoc Cancer Res 27: 107.Google Scholar
  96. Haddow A, Harris RJC, Kon GAR, Roe EMF (1948) The growth-inhibitory and carcinogenic properties of 4-aminostilbene and derivatives. Trans Roy Soc (London) A 241: 147–195.Google Scholar
  97. Hammons GJ, Guengerich FP, Weis CC, Beland FA, Kadlubar FF (1985) Metabolic oxidation of carcinogenic arylamines by rat, dog, and human hepatic microsomes and by purified flavin-containing and cytochrome P-450 monooxygenases. Cancer Res 45: 3578–3585.PubMedGoogle Scholar
  98. Harvan DJ, Hass JR, Lieberman MW (1977) Adduct formation between the carcinogen N-acetoxy-2-acetylaminofluorene and synthetic polydeoxyribonucleotides. Chem Biol Interact 17: 203–210.PubMedGoogle Scholar
  99. Hashimoto Y, Shudo K (1985) Modification of nucleic acids with 1-nitropyrene in the rat: identification of the modified nucleic acid base. Gann 76: 253–256.PubMedGoogle Scholar
  100. Hashimoto Y, Shudo K, Okamoto T (1979) Structural identification of a modified base in DNA covalently bound with mutagenic 3-amino-l-methyl-5/7-pyrido[4,3-6]indole. Chem Pharm Bull 27: 1058–1060.PubMedGoogle Scholar
  101. Hashimoto Y, Shudo K, Okamoto T (1980 a) Metabolic activation of a mutagen, 2-amino- 6-methyldipyrido[l,2-a:3/2’-d]imidazole. Identification of 2-hydroxyamino-6-methyl- dipyrido[l,2-a:3T-d]imidazole and its reaction with DNA. Biochem Biophys Res Commun 92: 971–976.Google Scholar
  102. Hashimoto Y, Shudo K, Okamoto T (1980 b) Activation of a mutagen, 3-amino-1 -methyl- 5H-pyrido[4,3-b]indole. Identification of 3-hydroxyamino-1-methyl-5H-pyrido[4,3- b]indole and its reaction with DNA. Biochem Biophys Res Commun 96: 355–362.Google Scholar
  103. Hashimoto Y, Shudo K, Okamoto T (1982 a) Modification of nucleic acids with muta-carcinogenic heteroaromatic amines in vivo. Identification of modified bases in DNA extracted from rats injected with 3-amino-l-methyl-5//-pyrido[4,3-&]mdole and 2- amino-6-methyldipyrido[1, 2-a:3’2’-d]imidazole. Mutation Res 105: 9–13.Google Scholar
  104. Hashimoto Y, Shudo K, Okamoto T (1982 b) Modification of DNA with potent mutacar- cinogenic 2-amino-6-methyldipyrido[1,2-a:3’2’-d]imidazole isolated from a glutamic acid pyrolysate: structure of the modified nucleic acid base and initial chemical event caused by the mutagen. J Am Chem Soc 104: 7636–7640.Google Scholar
  105. Heflich RH, Fifer EK, Djuric Z, Beland FA (1985 a) DNA adduct formation and mutation induction by nitropyrenes in Salmonella and Chinese hamster ovary cells: relationships with nitroreduction and acetylation. Environ Health Perspect 62: 135–143.Google Scholar
  106. Heflich RH, Howard PC, Beland FA (1985b) 1-Nitrosopyrene: an intermediate in the metabolic activation of 1-nitropyrene to a mutagen in Salmonella typhimurium TAI 538. Mutation Res 149: 25–32.Google Scholar
  107. Heflich RH, Djuric Z, Fifer EK, Cerniglia CE, Beland FA ( 1986 a) Metabolism of dinitropyrenes to DNA-binding derivatives in vitro and in vivo. In: Ishinishi N, Koizumi A, McClellan RO, Stöber W (eds) Carcinogenic and mutagenic effects of diesel engine exhaust. Elsevier, Amsterdam, pp 185–197.Google Scholar
  108. Heflich RH, Fullerton NF, Beland FA (1986 b) An examination of the weak mutagenic response of 1-nitropyrene in Chinese hamster ovary cells. Mutation Res 161: 99–108.Google Scholar
  109. Heflich RH, Morris SM, Beranek DT, McGarrity LJ, Chen J J, Beland FA (1986 c) Relationships between the DNA adducts and the mutations and sister-chromatid ex-changes produced in Chinese hamster ovary cells by N-hydroxy-2-aminofluorene, N- hydroxy-N-acetylbenzidine and 1-nitrosopyrene. Mutagenesis 1: 201–206.Google Scholar
  110. Heflich RH, Djuric Z, Zhuo Z, Fullerton NF, Casciano DA, Beland FA (1988) Metabolism of 2-acetylaminofluorene in the Chinese hamster ovary cell mutation assay. Environ Mol Mutagen 11: 167–181.PubMedGoogle Scholar
  111. Hein DW (1988) Acetylator genotype and arylamine-induced carcinogenesis. Biochim Biophys Acta 948: 37–66.PubMedGoogle Scholar
  112. Hein DW, Flammang TJ, Kirlin WG, Trinidad A, Ogolla F (1987) Acetylator genotype-dependent metabolic activation of carcinogenic N-hydroxyarylamines by -acetyl coenzyme A-dependent enzymes of inbred hamster tissue cytosols: relationship to arylamine N-acetyltransferase. Carcinogenesis 8: 1767–1774.PubMedGoogle Scholar
  113. Hilpert D, Neumann H-G (1985) Accumulation and elimination of macromolecular lesions in susceptible and non-susceptible rat tissues after repeated administration of rms-4-acetylaminostilbene. Chem Biol Interact 54: 85–95.PubMedGoogle Scholar
  114. Hilpert D, Romen W, Neumann H-G (1983) The role of partial hepatectomy and of promoters in the formation of tumors in non-target tissues of trans-4- acetylaminostilbene in rats. Carcinogenesis 4: 1519–1525.PubMedGoogle Scholar
  115. Hingerty B, Broyde S (1982) Conformation of the deoxydinucleoside monophosphate dCpdG modified at carbon 8 of guanine with 2-(acetylamino)fluorene. Biochemistry 21: 3243–3252.PubMedGoogle Scholar
  116. Hingerty B, Broyde S (1983) AAF linked to the guanine amino group: a B-Z junction. Nucleic Acids Res 11: 3241–3254.PubMedGoogle Scholar
  117. Hingerty BE, Broyde S (1986) Energy minimized structures of carcinogen-DNA adducts: 2-acetylaminofluorene and 2-aminofluorene. J Biomolecular Structure Dynamics 4: 365–372.Google Scholar
  118. Hirose M, Lee M-S, Wang CY, King CM (1984) Induction of rat mammary gland tumors by 1-nitropyrene, a recently recognized environmental mutagen. Cancer Res 44: 1158–1162.PubMedGoogle Scholar
  119. Howard AJ, Mitchell CE, Dutcher JS, Henderson TR, McClellan RO (1986) Binding of nitropyrenes and benzopyrene to mouse lung deoxyribonucleic acid after pretreatment with inducing agents. Biochem Pharmacol 35: 2129–2134.PubMedGoogle Scholar
  120. Howard PC, Beland FA (1982) Xanthine oxidase catalyzed binding of 1-nitropyrene to DNA. Biochem Biophys Res Commun 104: 727–732.PubMedGoogle Scholar
  121. Howard PC, Beland FA, Casciano DA (1981) Quantitation of iV-hydroxy-2- acetylaminofluorene mediated DNA adduct formation and the subsequent repair in primary rat hepatocyte cultures. J Supramol Struc Cell Biochem [Suppl] 5: 197.Google Scholar
  122. Howard PC, Heflich RH, Evans FE, Beland FA (1983) Formation of DNA adducts in vitro and in Salmonella typhimurium upon metabolic reduction of the environmental mutagen 1-nitropyrene. Cancer Res 43: 2052–2058.PubMedGoogle Scholar
  123. Howard PC, Flammang TJ, Beland FA (1985) Comparison of the in vitro and in vivo hepatic metabolism of the carcinogen 1-nitropyrene. Carcinogenesis 6: 243–249.PubMedGoogle Scholar
  124. Hueper WC, Wiley FH, Wolfe HD, Ranta KE, Leming MF, Blood FR (1938) Experimental production of bladder tumors in dogs by administration of -naphthylamine. J Ind Hyg Toxicol 20: 46–84.Google Scholar
  125. Hulbert PB, Grover PL (1983) Chemical rearrangement of phenol-epoxide metabolites of polycyclic aromatic hydrocarbons to quinone-methides. Biochem Biophys Res Commun 117: 129–134.PubMedGoogle Scholar
  126. IARC (1972) I ARC monographs of the evaluation of carcinogenic risk of chemicals to man, vol 1. 4-Aminobiphenyl. International Agency for Research on Cancer. World Health Organization, Lyon, pp 74–79.Google Scholar
  127. IARC (1974) I ARC monographs of the evaluation of carcinogenic risk of chemicals to man, vol 4. Some aromatic amines, hydrazine and related substances, N-nitroso compounds and miscellaneous alkylating agents. 2-Naphthylamine. International Agency for Research on Cancer. World Health Organization, Lyon, pp 97–111.Google Scholar
  128. IARC (1982) I ARC monographs of the evaluation of carcinogenic risk of chemicals to man, vol 29. Some industrial chemicals and dyestuffs. Benzidine and its sulphate, hydrochloride and dihydrochloride. International Agency for Research on Cancer. World Health Organization, Lyon, pp 149–183.Google Scholar
  129. Ilett KF, David BM, Detchon P, Castleden WM, Kwa R (1987) Acetylation phenotype in colorectal carcinoma. Cancer Res 47: 1466–1469.PubMedGoogle Scholar
  130. Jackson CD, Irving CC (1972) Sex differences in cell proliferation and iV-hydroxy-2- acetylaminofluorene sulfotransferase levels in rat liver during 2-acetylaminofluorene administration. Cancer Res 32: 1590–1594.PubMedGoogle Scholar
  131. Johnson DE, Cornish HH (1978) Metabolic conversion of 1- and 2-nitronaphthalene to 1-and 2-naphthylamine in the rat. Toxicol Appl Pharmacol 46: 549–553.PubMedGoogle Scholar
  132. Josephy PD, Eling TE, Mason RP (1983 a) An electron spin resonance study of the activation of benzidine by peroxidases. Mol Pharmacol 23: 766–770.Google Scholar
  133. Josephy PD, Eling TE, Mason RP (1983 b) Co-oxidation of benzidine by prostaglandin synthase and comparison with the action of horseradish peroxidase. J Biol Chem 258: 5561–5569.Google Scholar
  134. Kadlubar FF, Beland FA (1985) Chemical properties of ultimate carcinogenic metabolites of arylamines and arylamides. In: Harvey RG (ed) Polycyclic hydrocarbons and carcinogenesis. American Chemical Society, Washington DC, pp 341–370.Google Scholar
  135. (ACS symposium series no. 283)
    Kadlubar FF, Hammons GJ (1987) The role of cytochrome P-450 in the metabolism of chemical carcinogens. In: Guengerich FP (ed) Mammalian cytochromes P-450, vol II. CRC Press, Boca Raton, pp 81–130.Google Scholar
  136. Kadlubar FF, Miller JA, Miller EC (1976 a) Microsomal iV-oxidation of the hepatocarcinogen Armethyl-4-aminoazobenzene and the reactivity of N-hydroxy-N-methyl-4- aminoazobenzene. Cancer Res 36: 1196–1206.Google Scholar
  137. Kadlubar FF, Miller JA, Miller EC (1976 b) Hepatic metabolism of iV-hydroxy-iV-methyl- 4-aminoazobenzene and other iV-hydroxy arylamines to reactive sulfuric acid esters. Cancer Res 36: 2350–2359.Google Scholar
  138. Kadlubar FF, Miller JA, Miller EC (1977) Hepatic microsomal JV-glueuronidation and nucleic acid binding of N-hydroxy arylamines in relation to urinary bladder carcinogenesis. Cancer Res 37: 805–814.PubMedGoogle Scholar
  139. Kadlubar FF, Miller JA, Miller EC (1978) Guanyl 06-arylamination and 06-arylation of DNA by the carcinogen N-hydroxy-1 -naphthylamine. Cancer Res 38: 3628–3638.PubMedGoogle Scholar
  140. Kadlubar FF, Unruh LE, Beland FA, Straub KM, Evans FE (1980) In vitro reaction of the carcinogen,]V-hydroxy-2-naphthylamine, with DNA at the C-8 and N2 atoms of guanine and at the N6 atom of adenine. Carcinogenesis 1: 139–150.Google Scholar
  141. Kadlubar FF, Anson JF, Dooley KL, Beland FA (1981a) Formation of urothelial and hepatic DNA adducts from the carcinogen 2-naphthylamine. Carcinogenesis 2: 467–470.PubMedGoogle Scholar
  142. Kadlubar FF, Melchior WB Jr, Flammang TJ, Gagliano AG, Yoshida H, Geacintov NE (1981b) Structural consequences of modification of the oxygen atom of guanine in DNA by the carcinogen N-hydroxy-l-naphthylamine. Cancer Res 41: 2168–2174.PubMedGoogle Scholar
  143. Kadlubar FF, Unruh LE, Flammang TJ, Sparks D, Mitchum RK, Mulder GJ (1981c) Alteration of urinary levels of the carcinogen, N-hydroxy-2-naphthylamine, and its N- glucuronide in the rat by control of urinary pH, inhibition of metabolic sulfation, and changes in biliary excretion. Chem Biol Interact 33: 129–147.PubMedGoogle Scholar
  144. Kadlubar FF, Beland FA, Beranek DT, Dooley KL, Heflich RH, Evans FE ( 1982 a) Arylamine-DNA adduct formation in relation to urinary bladder carcinogenesis and Salmonella typhimurium mutagenesis. In: Sugimura T, Kondo S, Takebe H (eds) Environmental mutagens and carcinogens. Liss, New York, pp 385–396.Google Scholar
  145. Kadlubar FF, Frederick CB, Weis CC, Zenser TV (1982 b) Prostaglandin endoperoxide synthetase-mediated metabolism of carcinogenic aromatic amines and their binding to DNA and protein. Biochem Biophys Res Commun 108: 253–258.Google Scholar
  146. Kadlubar FF, Butler MA, Hayes BE, Beland FA, Guengerich FP ( 1988 a) Role of microsomal cytochromes P-450 and prostaglandin H synthase in 4-aminobiphenyl-DNA adduct formation. In: Miners J, Birkett DJ, Drew R, McManus M (eds). Microsomes and drug oxidations. Taylor and Francis, London, pp 370–379.Google Scholar
  147. Kadlubar FF, Dooley KL, Benson RW, Roberts DW, Butler MA, Teitel CH, Bailey JR, Young JF ( 1988 b) Pharmacokinetic model of aromatic amine-induced urinary bladder carcinogenesis in beagle dogs administered 4-aminobiphenyl. In: King CM, Romano LJ, Schuetzle D (eds) Carcinogenic and mutagenic responses to aromatic amines and nitroarenes. Elsevier, New York, pp 173–1840.Google Scholar
  148. Kadlubar FF, Guengerich FP, Butler MA, Delclos KB ( 1988 c) Cytochromes P-450 as determinants of susceptibility to carcinogenesis by aromatic amines and nitroaromatic hydrocarbons. In: Feo F, Pani P, Columbano A, Garcea R (eds) Chemical carcinogenesis. Models and mechanisms. Plenum Corp., New York, pp 17–23.Google Scholar
  149. Kadlubar FF, Talaska G, Lang NP, Benson RW, Roberts DW (1988 d) Assessment of exposure and susceptibility to aromatic amine carcinogens. In: Bartsch H, Hemminki K, O’Neill IK (eds) Methods for detecting DNA damaging agents in humans: applications in cancer epidemiology and prevention. IARC scientific publications no. 89, Lyon, pp 166–174.Google Scholar
  150. Kadlubar FF, Butler MA, Culp SJ, Teitel CH, Fu PP, Shaikh AU, Delclos KB, Beland FA (1989) Metabolic activation of arylamine derivatives of carcinogenic polycyclic nitroaromatic hydrocarbons. In: Kato R, Estabrook RW, Cayen MN (eds) Xenobiotic metabolism and disposition. Taylor and Francis, London, pp 375–381.Google Scholar
  151. Kamataki T, Maeda K, Yamazoe Y, Matsuda N, Ishii K, Kato R (1983) A high-spin form of cytochrome P-450 highly purified from polychlorinated biphenyl-treated rats. Catalytic characterization and immunochemical quantitation in liver microsomes. Mol Pharmacol 24: 146–155.Google Scholar
  152. Kato R (1986) Metabolic activation of mutagenic heterocyclic aromatic amines from protein pyrolysates. CRC Crit Rev Toxicol 16: 307–348.Google Scholar
  153. Kato R, Yamazoe Y (1987) Metabolic activation and covalent binding to nucleic acids of carcinogenic heterocyclic amines from cooked foods and amino acid pyrolysates. Gann 78: 297–311.PubMedGoogle Scholar
  154. Kato R, Kamataki T, Yamazoe Y (1983) Ar-Hydroxylation of carcinogenic and mutagenic aromatic amines. Environ Health Perspect 49: 21–25.PubMedGoogle Scholar
  155. Kawakubo Y, Manabe S, Yamazoe Y, Nishikawa T, Kato R (1988) Properties of cutaneous acetyltransferase catalyzing N- and 0-acetylation of carcinogenic aryl- amines and N-hydroxyarylamine. Biochem Pharmacol 37: 265–270.PubMedGoogle Scholar
  156. Kawano S, Kamataki T, Maeda K, Kato R, Nakao T, Mizoguchi I (1985) Activation and inactivation of a variety of mutagenic compounds by the reconstituted system containing highly purified preparations of cytochrome P-450 from rat liver. Fundam Appl Toxicol 5: 487–498.PubMedGoogle Scholar
  157. Kennelly JC, Beland FA, Kadlubar FF, Martin CN (1984) Binding of N-acetylbenzidine and JV,N’-diacetylbenzidine to hepatic DNA of rat and hamster in vivo and in vitro. Carcinogenesis 5: 407–412PubMedGoogle Scholar
  158. Kimura T, Kodama M, Nagata C (1982) N-Hydroxylation enzymes of carcinogenic aminoazo dyes: possible involvement of cytochrome P-448. Gann 73: 55–62.Google Scholar
  159. Kimura T, Kodama M, Nagata C (1984) Role of cytochrome P-450 and flavin-containing monooxygenase in the N-hydroxylation of N-methyl-4-aminoazobenzene in rat liver: analysis with purified enzymes and antibodies. Gann 75: 895–904.PubMedGoogle Scholar
  160. Kimura T, Kodama M, Nagata C, Kamataki T, Kato R (1985) Comparative study on the metabolism of JV-methyl-4-aminoazobenzene by two forms of cytochrome P-448. Biochem Pharmacol 34: 3375–3377.PubMedGoogle Scholar
  161. King CM (1974) Mechanism of reaction, tissue distribution, and inhibition of arylhydroxamic acid acyltransferase. Cancer Res 34: 1503–1515.PubMedGoogle Scholar
  162. King CM (1988) Metabolism and biological effects of nitropyrene and related compounds. Health Effects Institute, Cambridge, pp 1–22 (Health Effects Institute research report no. 16 )Google Scholar
  163. King CM, Glowinski IB (1983) Acetylation, deacetylation and acyltransfer. Environ Health Persp 49: 43–50.Google Scholar
  164. King CM, Phillips B (1969) TV-Hydroxy-2-fluorenylacetamide. Reaction of the carcinogen with guanosine, ribonucleic acid, deoxyribonucleic acid, and protein following enzymatic deacetylation or esterification. J Biol Chem 244: 6209–6216.Google Scholar
  165. King CM, Traub NR, Lortz ZM, Thissen MR (1979) Metabolic activation of aryl- hydroxamic acids by N-O-acyltransferase of rat mammary gland. Cancer Res 39: 3369–3372.PubMedGoogle Scholar
  166. Kinoshita R (1937) The cancerogenic chemical substances. Trans Soc Pathol Jpn 27: 665–725.Google Scholar
  167. Kinouchi T, Ohnishi Y (1986) Metabolic activation of 1-nitropyrene and 1,6-dinitropyrene by nitroreductases from Bacteroides fragilis and distribution of nitroreductase activity in rats. Microbiol Immunol 30: 979–992.PubMedGoogle Scholar
  168. Kinouchi T, Morotomi M, Mutai M, Fifer EK, Beland FA, Ohnishi Y (1986 a) Metabolism of 1-nitropyrene in germ-free and conventional rats. Gann 77: 356–369.Google Scholar
  169. Kinouchi T, Tsutsui H, Ohnishi Y (1986 b) Detection of 1-nitropyrene in yakitori (grilled chicken). Mutation Res 171: 105–113.Google Scholar
  170. Krauss RS, Eling TE (1985) Formation of unique arylamine:DNA adducts from 2- aminofluorene activated by prostaglandin H synthase. Cancer Res 45: 1680–1686.PubMedGoogle Scholar
  171. Kriek E (1965) On the interaction of 7Vr-2-fluorenylhydroxylamine with nucleic acids in vitro. Biochem Biophys Res Commun 20: 793–799.PubMedGoogle Scholar
  172. Kriek E (1969) On the mechanism of action of carcinogenic aromatic amines. I. Binding of 2-acetylaminofluorene and iV-hydroxy-2-acetylaminofluorene to rat-liver nucleic acids in vivo. Chem Biol Interact 1: 3–17.PubMedGoogle Scholar
  173. Kriek E (1971) On the mechanism of action of carcinogenic aromatic amines. II. Binding of 7V-hydroxy-Af-acetyl-4-aminobiphenyl to rat-liver nucleic acids in vivo. Chem Biol Interact 3: 19–28.PubMedGoogle Scholar
  174. Kriek E (1972) Persistent binding of a new reaction product of the carcinogen N-hydroxy- AT-2-acetylaminofluorene with guanine in rat liver DNA in vivo. Cancer Res 32: 2042–2048.PubMedGoogle Scholar
  175. Kriek E, Hengeveld GM (1977) Interaction of the carcinogen N-4-(4’-fluorobi- phenyl)acetamide (4T-4BAA) with DNA in liver and kidney of the rat. Colloques internationaux du CNRS 256: 115–118.Google Scholar
  176. Kriek E, Hengeveld GM (1978) Reaction products of the carcinogen iV-hydroxy-4-acetylamino-4’-fluorobiphenyl with DNA in liver and kidney of the rat. Chem Biol Interact 21: 179–201.PubMedGoogle Scholar
  177. Kriek E, Reitsema J (1971) Interaction of the carcinogen N-acetoxy-7V–2-acetylamino- fluorene with polyadenylic acid: dependence of reactivity on conformation. Chem Biol Interact 3: 397–400.PubMedGoogle Scholar
  178. Kriek E, Spelt CE (1979) Differential excision from DNA of the C-8 deoxyguanosine reaction products of N-hydroxy-2-aminofluorene and N-acetoxy-N-acetyl-2- aminofluorene by endonuclease St from Aspergillus oryzae. Cancer Lett 7: 147–154.PubMedGoogle Scholar
  179. Kriek E, Westra JG (1979) Metabolic activation of aromatic amines and amides and interactions with nucleic acids. In: Grover PL (ed) Chemical carcinogens and DNA, vol II. CRC Press, Boca Raton, pp 1–28.Google Scholar
  180. Kriek E, Westra JG (1980) Structural identification of the pyrimidine derivatives formed from N-(deoxyguanosin-8-yl)-2-aminofluorene in aqueous solution at alkaline pH. Carcinogenesis 1: 459–468.PubMedGoogle Scholar
  181. Kuchlbauer J, Romen W, Neumann H-G (1985) Syncarcinogenic effects on the initiation of rat liver tumors by ¿ra«s-4-acetylaminostilbene and 2-acetylaminofluorene. Carcinogenesis 6: 1337–1342.PubMedGoogle Scholar
  182. Lai C-C, Miller JA, Miller EC, Liem A (1985) Sulfoöxy-2-aminofluorene is the major ultimate electrophilic and carcinogenic metabolite of N-hydroxy-2-acetylamino- fluorene in the Overs of infant male C57BL/6J x C3H/HeJ F1 (B6C3FX) mice. Carcinogenesis 6: 1037–1045.PubMedGoogle Scholar
  183. Lai C-C, Miller EC, Miller JA, Liem A (1987) Initiation of hepatocarcinogenesis in infant male B6C3Ft mice by N-hydroxy-2-aminofluorene or N-hydroxy-2-acetyl- aminofluorene depends primarily on metabolism to JV-sulfooxy-2-aminofluorene and formation of DNA-(deoxyguanosin-8-yl)-2-aminofluorene adduets. Carcinogenesis 8: 471–478.Google Scholar
  184. Lambelin G, Roba J, Roncucci R, Parmentier R (1975) Carcinogenicity of 6-aminochrysene in mice. Eur J Cancer 11: 327–334.PubMedGoogle Scholar
  185. Lang NP, Chu DZJ, Hunter CF, Kendall DC, Flammang TJ, Kadlubar FF (1986) Role of aromatic amine acetyltransferase in human colorectal cancer. Arch Surg 121: 1259–1261.PubMedGoogle Scholar
  186. Lavine AF, Fink LM, Weinstein IB, Grunberger D (1974) Effect of N-2- acetylaminofluorene modification on the conformation of nucleic acids. Cancer Res 34: 319–327.Google Scholar
  187. Lefevre J-F, Fuchs RPP, Daune MP (1978) Comparative studies on the 7-iodo and 7- fluoro derivatives of N-aeetoxy-N-2-acetylaminofluorene: binding sites on DNA and conformational change of modified deoxytrinucleotides. Biochemistry 17: 2561–2567.PubMedGoogle Scholar
  188. Leichtenstern O (1898) Uber Harnblasenentzündung und Harnblasengeschwulste bei Arbeitern in Farbfabriken. Deut Med Wochenschr 24: 709–713.Google Scholar
  189. Leng M, Ptak M, Rio P (1980) Conformation of acetylaminofluorene and aminofluorene modified guanosine and guanosine derivatives. Biochem Biophys Res Commun 96: 1095–1102.PubMedGoogle Scholar
  190. Levine WG, Lu AYH (1982) Role of isozymes of cytochrome P-450 in the metabolism of A-Af-dimethyl-4-aminoazobenzene in the rat. Drug Metab Dispos 10: 102–109.PubMedGoogle Scholar
  191. Levy GN, Weber WW (1988) HPLC analysis of 32P-postlabeled DNA-2-amino- fluorene adduets. In: King CM, Romano LJ, Schuetzle D (eds) Carcinogenic and mutagenic responses to aromatic amines and nitroarenes. Elsevier, New York, pp 283–287.Google Scholar
  192. Lin J-K, Miller JA, Miller EC (1975 a) Structures of hepatic nucleic acid-bound dyes in rats given the carcinogen N-methyl-4-aminoazobenzene. Cancer Res 35: 844–850.Google Scholar
  193. Lin J-K, Schmall B, Sharpe ID, Miura I, Miller JA, Miller EC (1975 b) TV-Substitution of carbon 8 in guanosine and deoxyguanosine by the carcinogen N-benzoyloxy-N-methyl- 4-aminoazobenzene in vitro. Cancer Res 35: 832–843.Google Scholar
  194. Lipkowitz KB, Chevalier T, Widdifield M, Beland FA (1982) Force field conformational analysis of aminofluorene and acetylaminofluorene substituted deoxyguanosine. Chem Biol Interact 40: 57–76.PubMedGoogle Scholar
  195. Löfroth G, Hefner E, Alfheim I, Moller M (1980) Mutagenic activity in photocopies. Science 209: 1037–1039.PubMedGoogle Scholar
  196. Lotlikar PD, Luha L (1971) Acetylation of the carcinogen iV-hydroxy-2-ace- tylaminofluorene by acetyl coenzyme A to form a reactive ester. Mol Pharmacol 7: 381–388.PubMedGoogle Scholar
  197. Lynn RK, Garvie-Gould CT, Milam DF, Scott KF, Eastman CL, Ilias AM, Rodgers RM (1984) Disposition of the aromatic amine, benzidine, in the rat: characterization of mutagenic urinary and biliary metabolites. Tox Appl Pharmacol 72: 1–14.Google Scholar
  198. Maeda T, Izumi K, Otsuka H, Manabe Y, Kinouchi T, Ohnishi Y (1986) Induction of squamous cell carcinoma in the rat lung by 1,6-dinitropyrene. JNCI 76: 693–701.Google Scholar
  199. Mäher VM, Hazard RM, Beland FA, Corner R, Mendrala AL, Levinson JW, Heflich RH, McCormick J J (1980) Excision of the deacetylated C-8-guanine DNA adduct by human fibroblasts correlates with decreased cytotoxicity and mutagenicity. Proc Am Assoc Cancer Res 21: 71.Google Scholar
  200. Mäher VM, Heflich RH, McCormick JJ (1981) Repair of DNA damage induced in human fibroblasts by TV-substituted aryl compounds. Natl Cancer Inst Monogr 58: 217–222.PubMedGoogle Scholar
  201. Martin CN, Beland FA, Roth RW, Kadlubar FF (1982) Covalent binding of benzidine and N-acetylbenzidine to DNA at the C-8 atom of deoxyguanosine in vivo and in vitro. Cancer Res 42: 2678–2686.PubMedGoogle Scholar
  202. Martin CN, Beland FA, Kennelly JC, Kadlubar FF (1983) Binding of benzidine, N- acetylbenzidine, iV,iV-diacetylbenzidine and Direct Blue 6 to rat liver DNA. Environ Health Perspect 49: 101–106.PubMedGoogle Scholar
  203. Masson HA, Ioannides C, Gorrod JW, Gibson GG (1983) The role of highly purified cytochrome P-450 isozymes in the activation of 4-aminobiphenyl to mutagenic products in the Ames test. Carcinogenesis 4: 1583–1586.PubMedGoogle Scholar
  204. Matthews J J, Walpole AL (1958) Tumours of the liver and kidney induced in Wistar rats with 4/-fluoro-4-aminodiphenyl. Br J Cancer 12: 234–241.PubMedGoogle Scholar
  205. McCoy EC, Rosenkranz HS, Mermelstein R (1981) Evidence for the existence of a family of bacterial nitroreductases capable of activating nitrated polycyclics to mutagens. Environ Mutagenesis 3: 421–427.Google Scholar
  206. McCoy EC, McCoy GD, Rosenkranz HS (1982) Esterification of arylhydroxylamines: evidence for a specific gene product in mutagenesis. Biochim Biophys Res Commun 108: 1362–1367.Google Scholar
  207. McCoy EC, Anders M, Rosenkranz HS (1983) The basis of the insensitivity of Salmonella typhimurium strain TA98/1,8-DNP6 to the mutagenic action of nitroarenes. Mutation Res 121: 17–23PubMedGoogle Scholar
  208. McMahon RE, Turner JC, Whitaker GW (1980) The N-hydroxylation and ring-hydroxylation of 4-aminobiphenyl in vitro by hepatic monooxygenases from rat, mouse, hamster, rabbit and guinea-pig. Xenobiotica 10: 469–481.PubMedGoogle Scholar
  209. McQueen CA, Maslansky CJ, Glowinski IB, Crescenzi SB, Weber WW, Wilhams GM (1982) Relationship between the genetically determined acetylator phenotype and DNA damage induced by hydralazine and 2-aminofluorene in cultured rabbit hepatocytes. Proc Natl Acad Sci USA 79: 1269–1272.PubMedGoogle Scholar
  210. McQueen CA, Way BM, Williams GM (1987) Biotransformation of aromatic amines to DNA-damaging products by urinary bladder organ cultures. Carcinogenesis 8: 401–404.PubMedGoogle Scholar
  211. Meerman JHN (1985) The initiation of y-glutamyltranspeptidase positive foci in the rat liver by 7V-hydroxy-2-acetylaminofluorene. The effect of the sulfation inhibitor pentachlorophenol. Carcinogenesis 6: 893–897.PubMedGoogle Scholar
  212. Meerman JHN, Mulder GJ (1981) Prevention of the hepatotoxic action of N-hydroxy-2- acetylaminofluorene in the rat by inhibition of N-O-sulfation by pentachlorophenol. Life Sciences 28: 2361–2365.PubMedGoogle Scholar
  213. Meerman JHN, Beland FA, Mulder GJ (1981) Role of sulfation in the formation of DNA adducts from iV-hydroxy-2-acetylaminofluorene in rat liver in vivo. Inhibition of N- acetylated aminofluorene adduct formation by pentachlorophenol. Carcinogenesis 2: 413–416.Google Scholar
  214. Melchior WB Jr, Beland FA (1984) Preferential reaction of the carcinogen JV-acetoxy-2- acetylaminofluorene with satellite DNA. Chem Biol Interact 49: 177–187.PubMedGoogle Scholar
  215. Mermelstein R, Kiriazides DK, Butler M, McCoy EC, Rosenkranz HS (1981) The extraordinary mutagenicity of nitropyrenes in bacteria. Mutation Res 89: 187–196.PubMedGoogle Scholar
  216. Miller EC, Sandin RB, Miller J A, Rusch HP (1956) The carcinogenicity of compounds related to 2-acetylaminofluorene. III. Aminobiphenyl and benzidine derivatives. Cancer Res 16: 525–534.Google Scholar
  217. Miller EC, Lotlikar PD, Pitot HC, Fletcher TL, Miller J A (1966) iV-Hydroxy metabolites of 2-acetylaminophenanthrene and 7-fluoro-2-acetylaminofluorene as proximate carcinogens in the rat. Cancer Res 26: 2239–2247.Google Scholar
  218. Miller EC, Kadlubar FF, Miller JA, Pitot HC, Drinkwater NR (1979) The iV-hydroxy metabolites of iV-methyl-4-aminoazobenzene and related dyes as proximate carcinogens in the rat and mouse. Cancer Res 39: 3411–3418.PubMedGoogle Scholar
  219. Miller J A, Miller EC (1983) Some historical aspects of N-aryl carcinogens and their metabolic activation. Environ Health Perspect 49: 3–12.PubMedGoogle Scholar
  220. Miller J A, Sandin RB, Miller EC, Rusch HP (1955) The carcinogenicity of compounds related to 2-acetylaminofluorene. II. Variations in the bridges and the 2-substituent. Cancer Res 15: 188–199.PubMedGoogle Scholar
  221. Mita S, Yamazoe Y, Kamataki T, Kato R (1982) Effects of ascorbic acid on the non- enzymatic binding to DNA and the mutagenicity of N-hydroxylated metabolite of a tryptophan-pyrolysis product. Biochem Biophys Res Commun 105: 1396–1401.PubMedGoogle Scholar
  222. Mitchell CE (1985) Effect of aryl hydrocarbon hydroxylase induction on the in vivo covalent binding of 1-nitropyrene, benzo[a]pyrene, 2-aminoanthracene, and phen- anthridone to mouse lung deoxyribonucleic acid. Biochem Pharmacol 34: 545–551.PubMedGoogle Scholar
  223. Mitchell CE (1988) Formation of DNA adducts in mouse tissues after intratracheal instillation of 1-nitropyrene. Carcinogenesis 9: 857–860.PubMedGoogle Scholar
  224. Moller L, Corrie M, Midtvedt T, Rafter J, Gustafsson J-A (1988) The role of the intestinal microflora in the formation of mutagenic metabolites from the carcinogenic air pollutant 2-nitrofluorene. Carcinogenesis 9: 823–830.PubMedGoogle Scholar
  225. Mommsen S, Aagaard J (1983) Tobacco as a risk factor in bladder cancer. Carcinogenesis 4: 335–338.PubMedGoogle Scholar
  226. Moolgavkar SH, Stevens RG (1981) Smoking and cancers of bladder and pancreas: risks and temporal trends. JNCI 67: 15–23.Google Scholar
  227. Morton KC, King CM, Baetcke KP (1979) Metabolism of benzidine to N-hydroxy-N- diacetylbenzidine and subsequent nucleic acid binding and mutagenicity. Cancer Res 39: 3107–3113.PubMedGoogle Scholar
  228. Morton KC, Beland FA, Evans FE, Fullerton NF, Kadlubar FF (1980) Metabolic activation of N-hydroxy-N,N-diacetylbenzidine by hepatic sulfotransferase. Cancer Res 40: 751–757.PubMedGoogle Scholar
  229. Morton KC, Wang CY, Garner CD, Shirai T (1981) Carcinogenicity of benzidine, N,N’-diacetylbenzidine, and hydroxy-diacetylbenzidine for female CD rats. Carcinogenesis 2: 747–752.Google Scholar
  230. Morton KC, King CM, Vaught JB, Wang CY, Lee M-S, Marnett LJ (1983) Prostaglandin H synthase-mediated reaction of carcinogenic arylamines with tRNA and homopolyribonucleotides. Biochem Biophys Res Commun 111: 96–103.PubMedGoogle Scholar
  231. Murofushi Y, Hashimoto Y, Shudo K, Okamoto T (1981) Reaction of 1- naphthylhydroxylamine with calf thymus deoxyribonucleic acid. Isolation and synthesis of N-(guanin-C8-yl)-l-naphthylamine. Chem Pharm Bull 29: 2730–2732.PubMedGoogle Scholar
  232. National Cancer Institute (1978) Bioassay of 1-nitronaphthalene for possible carcinogenicity. Carcinogenesis tech rep ser no 64, pp 1–47.Google Scholar
  233. Neidle S, Kuroda R, Broyde S, Hingerty BE, Levine RA, Miller DW, Evans FE (1984) Studies on the conformation and dynamics of the C8-substituted guanine adduct of the carcinogen acetylaminofluorene: model for a possible Z-DNA modified structure. Nucleic Acids Res 12: 8219–8233.PubMedGoogle Scholar
  234. Nelson AA, Woodard G (1953) Tumors of the urinary bladder, gall bladder, and liver in dogs fed o-aminoazotoluene or dimethylaminoazobenzene. JNCI13: 1497–1509.Google Scholar
  235. Nelson CJ, Baetcke KP, Frith CH, Kodell RL, Schieferstein G (1982) The influence of sex, dose, time, and cross on neoplasia in mice given benzidine dihydrochloride. Toxicol Appl Pharmacol 64: 171–186.PubMedGoogle Scholar
  236. Nelson JH, Grunberger D, Cantor CR, Weinstein IB (1971) Modification of ribonucleic acid by chemical carcinogens. IV. Circular dichroism and proton magnetic resonance studies of oligonucleotides modified with 7V-2-acetylaminofluorene. J Mol Biol 62: 331–346.PubMedGoogle Scholar
  237. Nesnow S, Triplett LL, Slaga TJ (1984) Tumor initiating activities of 1-nitropyrene and its nitrated products in SENCAR mice. Cancer Lett 23: 1–8.PubMedGoogle Scholar
  238. Neumann H-G (1981) Significance of metabolic activation and binding to nucleic acids of aminostilbene derivatives in vivo. Natl Cancer Inst Monogr 58: 165–171.PubMedGoogle Scholar
  239. Nielsen T, Seitz B, Ramdahl T (1984) Occurrence of nitro-PAH in the atmosphere in a rural area. Atmospheric Environ 18: 2159–2165.Google Scholar
  240. Nussbaum M, Fiala ES, Kulkarni B, El-Bayoumy K, Weisburger JH (1983) In vivo metabolism of 3,2’-dimethyl-4-aminobiphenyl (DMAB) bearing on its organotropism in the Syrian golden hamster and the F344 rat. Environ Health Perspect 49: 223–231.PubMedGoogle Scholar
  241. Ohgaki H, Negishi C, Wakabayashi K, Kusama K, Sato S, Sugimura T (1984) Induction of sarcomas in rats by subcutaneous injection of dinitropyrenes. Carcinogenesis 5: 583–585.PubMedGoogle Scholar
  242. Ohgaki H, Hasegawa H, Kato T, Negishi C, Sato S, Sugimura T (1985) Absence of carcinogenicity of 1-nitropyrene, correction of previous results, and new demonstration of carcinogenicity of 1,6-dinitropyrene in rats. Cancer Lett 25: 239–245.PubMedGoogle Scholar
  243. Ohnishi Y, Kinouchi T, Tsutsui H, Uejima M, Nishifuji K (1986) Mutagenic nitropyrenes in foods. In: Hayashi Y, Nagao M, Sugimura T, Takayama S, Tomatis L, Wattenberg LW, Wogan GN (eds) Diet, nutrition and cancer. Japan Sci Soc Press, Tokyo, pp 107–118.Google Scholar
  244. Orr JC, Bryant DW, McCalla DR, Quilliam MA (1985) Dinitropyrene-resistant Salmonella typhimurium are deficient in an acetyl-CoA acetyltransferase. Chem Biol Interact 54: 281–288PubMedGoogle Scholar
  245. Otofuji T, Horikawa K, Maeda T, Sano N, Izumi K, Otsuka H, Tokiwa H (1987) Tumorigenicity test of 1,3- and 1,8-dinitropyrene in BALB/c mice. JNCI 79: 185–188.Google Scholar
  246. Parkes HG, Evans AEJ (1984) Epidemiology of aromatic amine cancers. In: Searle CE Chemical carcinogens, vol 1. American Chemical Society, Washington DC, pp 277–301. (ACS Monograph 182) Patrianakos C, Hoffmann D (1979) Chemical studies on tobacco smoke. LXIV. On the analysis of aromatic amines in cigarette smoke. J Anal Toxicol 3: 150–154.Google Scholar
  247. Patton JD, Maher VM, McCormick JJ (1986) Cytotoxic and mutagenic effects of 1-nitropyrene and 1-nitrosopyrene in diploid human fibroblasts. Carcinogenesis 7: 89–93.PubMedGoogle Scholar
  248. Pederson TC, Siak J-S (1981) The role of nitroaromatic compounds in the direct-acting mutagenicity of diesel particle extracts. J Appl Toxicol 1: 54–60.PubMedGoogle Scholar
  249. Petry TW, Krauss RS, Eling TE (1986) Prostaglandin H synthase-mediated bioactivation of the amino acid pyrolysate product Trp P-2. Carcinogenesis 7: 1397–1400.PubMedGoogle Scholar
  250. Poirier LA, Weisburger JH (1974) Enzymic reduction of carcinogenic aromatic nitro compounds by rat and mouse liver fractions. Biochem Pharmacol 23: 661–669.PubMedGoogle Scholar
  251. Poirier MC, Williams GM, Yuspa SH (1980) Effect of culture conditions, cell type, and species of origin on the distribution of acetylated and deacetylated deoxyguanosine C-8 adducts of iV-acetoxy-2-acetylaminofluorene. Mol Pharmacol 18: 581–587.PubMedGoogle Scholar
  252. Poirier MC, True B, Laishes BA (1982) Formation and removal of (guan-8-yl)DNA-2- acetylaminofluorene adducts in liver and kidney of male rats given dietary 2- acetylaminofluorene. Cancer Res 42: 1317–1321.PubMedGoogle Scholar
  253. Poirier MC, Hunt JM, True B, Laishes BA, Young JF, Beland FA (1984) DNA adduct formation, removal and persistence in rat liver during one month feeding of 2-acetylaminofluorene. Carcinogenesis 5: 1591–1596.PubMedGoogle Scholar
  254. Poirier MC, Fullerton NF, Beland FA (1988) DNA adduct formation and removal during chronic dietary administration of 2-acetylaminofluorene. In: King CM, Romano LJ, Schuetzle D (eds) Carcinogenic and mutagenic responses to aromatic amines and nitroarenes. Elsevier, New York, pp 321–328.Google Scholar
  255. Poupko JM, Hearn WL, Radomski JL (1979) iV-Glucuronidation of JV-hydroxy aromatic amines: a mechanism for their transport and bladder-specific carcinogenicity. Toxicol Appl Pharmacol 50: 479–184.Google Scholar
  256. Purchase IFH, Kalinowski AE, Ishmael J, Wilson J, Gore CW, Chart IS (1981) Lifetime carcinogenicity study of 1- and 2-naphthylamine in dogs. Br J Cancer 44: 892–901.PubMedGoogle Scholar
  257. Radomski JL (1979) The primary aromatic amines: their biological properties and structure-activity relationships. Ann Rev Pharmacol Toxicol 19: 129–157.Google Scholar
  258. Radomski JL, Brill E, Deichmann WB, Glass EM (1971) Carcinogenicity testing of N-hydroxy and other oxidation and decomposition products of 1- and 2-naphthylamine. Cancer Res 31: 1461–1467.PubMedGoogle Scholar
  259. Radomski JL, Deichmann WB, Altman NH, Radomski T (1980) Failure of pure 1-naphthylamine to induce bladder tumors in dogs. Cancer Res 40: 3537–3539.PubMedGoogle Scholar
  260. Ramdahl T, Becher G, Bj0rseth A (1982) Nitrated polycyclic aromatic hydrocarbons in urban air particles. Environ Sci Technol 16: 861–865.Google Scholar
  261. Reddy MV, Gupta RC, Randerath E, Randerath K (1984) 32P-Postlabeling test for covalent DNA binding of chemicals in vivo: application to a variety of aromatic carcinogens and methylating agents. Carcinogenesis 5: 231–243.Google Scholar
  262. Rehn L (1895) Blasengeschwiilste bei Fuchsin-Arbeitern. Arch Klin Chir 50: 588–600.Google Scholar
  263. Reprinted in translation: Shimkin MB (1980) Some classics of experimental oncology: 50 selections, 1775–1965.NIH publication no. 80–2150., pp 44–51.Google Scholar
  264. Rice JR, Kissinger PT (1982) Cooxidation of benzidine by horseradish peroxidase and subsequent formation of possible thioether conjugates of benzidine. Biochem Biophys Res Commun 104: 1312–1318.PubMedGoogle Scholar
  265. Ringer DP, Norton TR (1987) Further characterization of the ability of hepatocarcinogens to lower rat liver aryl sulfotransferase activity. Carcinogenesis 8: 1749–1752.PubMedGoogle Scholar
  266. Ringer DP, Kampschmidt K, King RL Jr, Jackson S, Kizer DE (1983) Rapid decrease in AT-hydroxy-2-acetylaminofluorene sulfotransferase activity of liver cytosols from rats fed carcinogen. Biochem Pharmacol 32: 315–319.PubMedGoogle Scholar
  267. Roe FJC, Carter RL, Adamthwaite S (1969) Induction of liver and lung tumours in mice by 6-aminochrysene administered during the first 3 days of life. Nature 221: 1063–1064.PubMedGoogle Scholar
  268. Rosenkranz HS, Mermelstein R (1983) Mutagenicity and genotoxicity of nitroarenes. All nitro-containing chemicals were not created equal. Mutation Res 114: 217–267.Google Scholar
  269. Rosenkranz HS, McCoy EC, Sanders DR, Butler M, Kiriazides DK, Mermelstein R (1980) Nitropyrenes: isolation, identification, and reduction of mutagenic impurities in carbon black and toners. Science 209: 1039–1043.PubMedGoogle Scholar
  270. Ruthsatz M, Neumann H-G (1988) Synergistic effects on the initiation of rat liver tumors by ra-4-acetylaminostilbene and 2-acetylaminofluorene, studied at the level of DNA adduct formation. Carcinogenesis 9: 265–269.PubMedGoogle Scholar
  271. Saffiotti U, Cefis F, Montesano R, Sellakumar AR (1967) Induction of bladder cancer in hamsters fed aromatic amines. In: Lampe KF, Penalver RA, Soto A (eds) Bladder cancer, a symposium. Aesculapius, Birmingham, pp 129–135.Google Scholar
  272. Sage E, Leng M (1980) Conformation of poly(dG-dC)poly (dG-dC) modified by the carcinogens N-acetoxy-N-acetyl-2-aminofluorene and 7V-hydroxy-iV-2-ammofluorene. Proc Natl Acad Sci USA 77: 4597–4601.PubMedGoogle Scholar
  273. Saito K, Kamataki T, Kato R (1984) Participation of cytochrome P-450 in reductive metabolism of 1-nitropyrene by rat liver microsomes. Cancer Res 44: 3169–3173.PubMedGoogle Scholar
  274. Saito K, Shinohara A, Kamataki T, Kato R (1985) Metabolic activation of mutagenic N- hydroxyarylamines by O-acetyltransferase in Salmonella typhimurium TA98. Arch Biochem Biophys 239: 286–295.PubMedGoogle Scholar
  275. Santella RM, Grunberger D, Broyde S, Hingerty BE (1981 a) Z-DNA conformation of N- 2-acetylaminofluorene modified poly (dG-dC) poly (dG-dC) determined by reactivity with anti cytidine antibodies and minimized potential energy calculations. Nucleic Acids Res 9: 5459–5467.Google Scholar
  276. Santella RM, Grunberger D, Weinstein IB, Rich A (1981 b) Induction of the Z conformation in poly (dG-dC) poly(dG-dC) by binding of N-2-acetylaminofluorene to guanine residues. Proc Natl Acad Sci USA 78: 1451–1455.Google Scholar
  277. Sato T, Kato K, Ose Y, Nagase H, Ishikawa T (1985) Nitroarenes in Suimon River sediment. Mutation Res 157: 135–143.PubMedGoogle Scholar
  278. Schuetzle D (1983) Sampling of vehicle emissions for chemical analysis and biological testing. Environ Health Persp 47: 65–80.Google Scholar
  279. Schuetzle D, Lee FS-C, Prater TJ, Tejada SB (1981) The identification of polynuclear aromatic hydrocarbon ( PAH) derivatives in mutagenic fractions of diesel particulate extracts. Intern J Environ Anal Chem 9: 93–144.Google Scholar
  280. Scribner JD, Fisk SR (1978) Reproduction of major reactions of aromatic carcinogens with guanosine, using HMO-based polyeleetronic perturbation theory. Tetrahedron Lett 4759–4762.Google Scholar
  281. Scribner JD, Koponen G (1979) Binding of the carcinogen 2-acetamidophenanthrene to rat liver nucleic acids: lack of correlation with carcinogenic activity, and failure of the hydroxamic acid ester model for in vivo activation. Chem Biol Interact 15: 201–209.Google Scholar
  282. Scribner JD, Mottet NK (1981) DDT acceleration of mammary gland tumors induced in the male Sprague-Dawley rat by 2-acetamidophenanthrene. Carcinogenesis 2: 1235–1239.PubMedGoogle Scholar
  283. Scribner JD, Naimy NK (1975) Adducts between the carcinogen 2-acet-amidophenanthrene and adenine and guanine of DNA. Cancer Res 35: 1416–1421.PubMedGoogle Scholar
  284. Scribner NK, Scribner JD (1979) Reactions of the carcinogen N-acetoxy-4-acet-amidostilbene with polynucleotides in vitro. Chem Biol Interact 26: 47–55.PubMedGoogle Scholar
  285. Scribner JD, Smith DL, McCloskey J A (1978) Deamination of 1-methylcytosine by the carcinogen JV-acetoxy-4-acetamidostilbene: implications for hydrocarbon carcino-genesis. J Org Chem 43: 2085–2087.Google Scholar
  286. Scribner JD, FiskSR, Scribner NK (1979a) Mechanisms of action of carcinogenic aromatic amines: an investigation using mutagenesis in bacteria. Chem Biol Interact 26: 11–25.Google Scholar
  287. Scribner NK, Scribner JD, Smith DL, Schram KH, McCloskey J A (1979 b) Reactions of the carcinogen TV-acetoxy-4-acetamidostilbene with nucleosides. Chem Biol Interact 26: 27–46.Google Scholar
  288. Scribner JD, Woodworth B, Koponen G, Holmes EH (1983) Use of 2-acetamido-phenanthrene and 2-acetamidofluorene in investigations of mechanisms of hepatocarcinogenesis. Environ Health Perspect 49: 81–86.PubMedGoogle Scholar
  289. Shapiro R, Underwood GR, Zawadzka H, Broyde S, Hingerty BE (1986) Conformation of d(CpG) modified by the carcinogen 4-aminobiphenyl: a combined experimental and theoretical analysis. Biochemistry 25: 2198–2205.PubMedGoogle Scholar
  290. Shinohara A, Saito K, Yamazoe Y, Kamataki T, Kato R (1985) DNA binding of N- hydroxy-Trp-P-2 and JV-hydroxy-Glu-P-1 by acetyl-CoA dependent enzyme in mam¬malian liver cytosol. Carcinogenesis 6: 305–307.PubMedGoogle Scholar
  291. Shinohara A, Saito K, Yamazoe Y, Kamataki T, Kato R (1986) Acetyl coenzyme A dependent activation of N-hydroxy derivatives of carcinogenic arylamines: mechanism of activation, species difference, tissue distribution, and acetyl donor specificity. Cancer Res 46: 4362–4367.PubMedGoogle Scholar
  292. Shirai T, Fysh JM, Lee M-S, Vaught JB, King CM (1981 a) Relationship of metabolic activation of N-hydroxy-AT-acylarylamines to biological response in the liver and mammary gland of the female CD rat. Cancer Res 41: 4346–4353.Google Scholar
  293. Shirai T, Lee M-S, Wang CY, King CM (1981b) Effects of partial hepatectomy and dietary phenobarbital on liver and mammary tumorigenesis by two TV-hydroxy-N- acylaminobiphenyls in female CD rats. Cancer Res 41: 2450–2456.PubMedGoogle Scholar
  294. Silverman DT, Hoover RN, Albert S, Graff KM (1983) Occupation and cancer of the lower urinary tract in Detroit. JNCI 70: 237–245.Google Scholar
  295. Snyderwine EG, Roller PP, Adamson RH, Sato S, Thorgeirsson SS (1988) Reaction of N- hydroxylamine and N-acetoxy derivatives of 2-amino-3-methylimidazolo[4,5]quinoline with DNA. Synthesis and identification of N-(deoxyguanosin-8-yl)-IQ. Carcinogenesis 9: 1061–1065.PubMedGoogle Scholar
  296. Spitz S, Maguigan WH, Dobriner K (1950) The carcinogenic action of benzidine. Cancer 3: 789–804.PubMedGoogle Scholar
  297. Spodheim-Maurizot M, Saint-Ruf G, Leng M (1979) Conformational changes induced in DNA by in vitro reaction with iV-hydroxy-iV-2-aminofluorene. Nucleic Acids Res 6: 1683–1694.PubMedGoogle Scholar
  298. Spodheim-Maurizot M, Saint-Ruf G, Leng M (1980) Antibodies to N-hydroxy-2- aminofluorene modified DNA as probes in the study of DNA reacted with derivatives of2-aeetylaminofluorene. Carcinogenesis 1: 807–812.PubMedGoogle Scholar
  299. Stanton CA, Chow FL, Phillips DH, Grover PL, Garner RC, Martin CN (1985) Evidence for N-(deoxyguanosin-8-yl)-1-aminopyrene as a major DNA adduct in female rats treated with 1-nitropyrene. Carcinogenesis 6: 535–538.PubMedGoogle Scholar
  300. Sternson LA (1975) Detection of arylhydroxylamines as intermediates in the metabolic reduction of nitro compounds. Experientia 31: 268–270.PubMedGoogle Scholar
  301. Sugimura T (1986) Past, present, and future of mutagens in cooked foods. Environ Health Perspect 67: 5–10.PubMedGoogle Scholar
  302. Sweetman JA, Karasek FW, Schuetzle D (1982) Decomposition of nitropyrene during gas chromatographic-mass spectrometric analysis of air particulate and fly-ash samples. J Chromatography 247: 245–254.Google Scholar
  303. Takayama S, Ishikawa T, Nakajima H, Sato S (1985) Lung carcinoma induction in Syrian golden hamsters by intratracheal instillation of 1,6-dinitropyrene. Gann 76: 457–461.PubMedGoogle Scholar
  304. Talaska G, Au WW, Ward JB Jr, Randerath K, Legator MS (1987) The correlation between DNA adducts and chromosomal aberrations in the target organ of benzidine exposed, partially-hepatectomized mice. Carcinogenesis 8: 1899–1905.PubMedGoogle Scholar
  305. Tang M-S, Lieberman MW, King CM (1982) uvr Genes function differently in repair of acetylaminofluorene and aminofluorene DNA adducts. Nature 299: 646–648.Google Scholar
  306. Tarpley WG, Miller JA, Miller EC (1980) Adducts from the reaction of N-benzoyloxy-N-methyl-4-aminoazobenzene with deoxyguanosine or DNA in vitro and from hepatic DNA of mice treated with N-methyl- or-dimethyl-4-aminoazobenzene. Cancer Res 40: 2493–2499.PubMedGoogle Scholar
  307. Tarpley WG, Miller JA, Miller EC (1982) Rapid release of carcinogen-guanine adducts from DNA after reaction with N-acetoxy-2-acetylaminofluorene or N-benzoyloxy-N- methyl-4-aminoazobenzene. Carcinogenesis 3: 81–88.PubMedGoogle Scholar
  308. Tatsumi K, Kitamura S, Narai N (1986) Reductive metabolism of aromatic nitro compounds including carcinogens by rabbit liver preparations. Cancer Res 46: 1089–1093.PubMedGoogle Scholar
  309. Tokiwa H, Ohnishi Y (1986) Mutagenicity and carcinogenicity of nitroarenes and their sources in the environment. CRC Crit Rev Toxicol 17: 23–60.Google Scholar
  310. Tokiwa H, Kitamori S, Nakagawa R, Horikawa K, Matamala L (1983) Demonstration of a powerful mutagenic dinitropyrene in airborne particulate matter. Mutation Res 121: 107–116.PubMedGoogle Scholar
  311. Tokiwa H, Otofuji T, Horikawa K, Kitamori S, Otsuka H, Manabe Y, Kinouchi T, Oh-nishi Y (1984) 1,6-Dinitropyrene: mutagenicity in Salmonella and carcinogenicity in BALB/cmice. JNCI 73: 1359–1363.Google Scholar
  312. Tokiwa H, Nakagawa R, Horikawa K (1985) Mutagenic/carcinogenic agents in indoor pollutants; the dinitropyrenes generated by kerosene heaters and fuel gas and liquefied petroleum gas burners. Mutation Res 157: 39–47.PubMedGoogle Scholar
  313. Tsuruta Y, Josephy PD, Rahimtula AD, O’Brien PJ (1985) Peroxidase-catalyzed benzidine binding to DNA and other macromolecules. Chem Biol Interact 54: 143–158.PubMedGoogle Scholar
  314. Tullis DL, Straub KM, Kadlubar FF (1981) A comparison of the carcinogen-DNA adducts formed in rat liver in vivo after administration of single or multiple doses of N- methyl-4-aminoazobenzene. Chem Biol Interact 38: 15–27.Google Scholar
  315. Tullis DL, Dooley KL, Miller DW, Baetcke KP, Kadlubar FF (1987) Characterization and properties of the DNA adducts formed from N-methyl-4-aminoazobenzene in rats during a carcinogenic treatment regimen. Carcinogenesis 8: 577–583.PubMedGoogle Scholar
  316. van Houte LPA, Bokma JT, Lutgerink JT, Westra JG, Retel J, van Grondelle R, Blok J (1987) An optical study of the conformation of the aminofluorene - DNA complex. Carcinogenesis 8: 759–766.PubMedGoogle Scholar
  317. Vesselinovitch SD, Rao KVN, Mihailovich N (1975) Factors modulating benzidine car¬cinogenicity bioassay. Cancer Res 35: 2814–2819.PubMedGoogle Scholar
  318. Visser A, Westra JG (1981) Partial persistency of 2-aminofluorene and N-acetyl-2- aminofluorene in rat liver DNA. Carcinogenesis 2: 737–740.PubMedGoogle Scholar
  319. Walpole AL, Williams MHC, Roberts DC (1952) The carcinogenic action of 4- aminodiphenyl and 3:2’-dimethyl-4-aminodiphenyl. Br J Ind Med 9: 255–263.PubMedGoogle Scholar
  320. Walpole AL, Wilhams MHC, Roberts DC (1954) Tumours of the urinary bladder in dogs after ingestion of 4-aminodiphenyl. Br J Ind Med 11: 105–109.PubMedGoogle Scholar
  321. Weber WW (1987) The acetylator genes and drug response. Oxford University Press, New York, pp 1–248.Google Scholar
  322. Wei C-I, Raabe OG, Rosenblatt LS (1982) Microbial detection of mutagenic nitro-organic compounds in filtrates of coal fly ash. Environ Mutagenesis 4: 249–258.Google Scholar
  323. Westra JG, Visser A (1979) Quantitative analysis of JV-(guanin-8-yl)-N-acetyl-2- aminofluorene and N-(guanin-8-yl)-2-aminofluorene in modified DNA by hydrolysis in trifluoroacetic acid and high pressure liquid chromatography. Cancer Lett 8: 155–162.PubMedGoogle Scholar
  324. Westra JG, Kriek E, Hittenhausen H (1976) Identification of the persistently bound form of the carcinogen JV-acetyl-2-aminofluorene to rat liver DNA in vivo. Chem Biol Interact 15: 149–164.PubMedGoogle Scholar
  325. Westra JG, Flammang TJ, Fullerton NF, Beland FA, Weis CC, Kadlubar FF (1985) Formation of DNA adducts in vivo in rat liver and intestinal epithelium after ad-ministration of the carcinogen 3,2’-dimethyl-4-aminobiphenyl and its hydroxamic acid. Carcinogenesis 6: 37–44.PubMedGoogle Scholar
  326. Wigle DT, Mao Y, Grace M (1980) Relative importance of smoking as a risk factor for selected cancers. Can J Public Health 71: 269–275.PubMedGoogle Scholar
  327. Williams MHC (1962) Environmental and industrial bladder cancer. Preventive measures. Acta Unio Int Contra Cancrum 18: 676–683.Google Scholar
  328. Wilson RH, DeEds F, Cox AJ Jr (1941) The toxicity and carcinogenic activity of 2-acetaminofluorene. Cancer Res 1: 595–608.Google Scholar
  329. Wise RW, Zenser TV, Davis BB (1984 a) Characterization of benzidinediimine: a product of peroxidase metabolism of benzidine. Carcinogenesis 5: 1499–1503.Google Scholar
  330. Wise RW, Zenser TV, Kadlubar FF, Davis BB (1984 b) Metabolic activation of carcinogenic aromatic amines by dog bladder and kidney prostaglandin H synthase. Cancer Res 44: 1893–1897.Google Scholar
  331. Wise RW, Zenser TV, Davis BB (1985) Prostaglandin H synthase oxidation of benzidine and o-dianisidine: reduction and conjugation of activated amines by thiols. Carcinogenesis 6: 579–583.PubMedGoogle Scholar
  332. Wiseman RW, Stowers SJ, Miller EC, Anderson MW, Miller JA (1986) Activating mutations of the c-Ha-ras protooncogene in chemically induced hepatomas of the male B6C3 Fx mouse. Proc Natl Acad Sci USA 83: 5825–5829.PubMedGoogle Scholar
  333. Wislocki PG, Bagan ES, Lu AYH, Dooley KL, Fu PP, Han-Hsu H, Beland FA, Kadlubar FF (1986) Tumorigenicity of nitrated derivatives of pyrene, benz[a]anthracene, chrysene and benzo[a]pyrene in the newborn mouse assay. Carcinogenesis 7: 1317–1322.PubMedGoogle Scholar
  334. Wynder EL, Goldsmith R (1977) The epidemiology of bladder cancer. A second look. Cancer 40: 1246–1268.Google Scholar
  335. Xu XB, Nachtman JP, Jin ZL, Wei ET, Rappaport SM, Burlingame AL (1982) Isolation and identification of mutagenic nitro-PAH in diesel-exhaust particulates. Anal Chim Acta 136: 163–174.Google Scholar
  336. Yamazoe Y, Shimada M, Kamataki T, Kato R (1983) Microsomal activation of 2-amino- 3-methylimidazo[4,5-/]quinoline, a pyrolysate of sardine and beef extracts, to a mutagenic intermediate. Cancer Res 43: 5768–5774.PubMedGoogle Scholar
  337. Yamazoe Y, Miller DW, Weis CC, Dooley KL, Zenser TV, Beland FA, Kadlubar FF (1985a) DNA adducts formed by nng-oxidation of the carcinogen 2-naphthylamine with prostaglandin H synthase in vitro and in the dog urothelium in vivo. Carcinogenesis 6: 1379–1387.PubMedGoogle Scholar
  338. Yamazoe Y, Shimada M, Shinohara A, Saito K, Kamataki T, Kato R (1985 b) Catalysis of the covalent binding of 3-hydroxyamino-l-methyl-5H-pyrido-[4,3–6]indole to DNA by a L-proline- and adenosine triphosphate-dependent enzyme in rat hepatic cytosol. Cancer Res 45: 2495–2500.Google Scholar
  339. Yamazoe Y, Roth RW, Kadlubar FF (1986) Reactivity of benzidine diimine with DNA to form N-(deoxyguanosin-8-yl)-benzidine. Carcinogenesis 7: 179–182.PubMedGoogle Scholar
  340. Yamazoe Y, Abu-Zeid M, Manabe S, Toyama S, Kato R (1988 a) Metabolic activation of a protein pyrolysate promutagen 2-amino-3,8-dimethylimidazo[4,5-/]-quinoxaline by rat liver microsomes and purified cytochrome P-450. Carcinogenesis 9: 105–109.Google Scholar
  341. Yamazoe Y, Zenser TV, Miller DW, Kadlubar FF (1988 b) Mechanism of formation and structural characterization of DNA adducts derived from peroxidative activation of benzidine. Carcinogenesis 9: 1635–1641.Google Scholar
  342. Young JF, Kadlubar FF (1982) A pharmacokinetic model to predict exposure of the bladder epithelium to urinary N-hydroxyarylamine carcinogens as a function of urine pH, voiding interval, and resorption. Drug Metab Dispos 10: 641–644.PubMedGoogle Scholar
  343. Zenser TV, Mattammal MB, Davis BB (1979) Cooxidation of benzidine by renal medullary prostaglandin cyclooxygenase. J Pharmacol Exp Ther 211: 460–464.PubMedGoogle Scholar
  344. Zenser TV, Mattammal MB, Armbrecht HJ, Davis BB (1980) Benzidine binding to nucleic acids mediated by the peroxidative activity of prostaglandin endoperoxide synthetase. Cancer Res 40: 2839–2845.PubMedGoogle Scholar
  345. Ziegler DM, Ansher SS, Nagata T, Kadlubar FF, Jakoby WB (1988) N-Methylation: potential mechanism for metabolic activation of carcinogenic primary arylamines. Proc Natl Acad Sci USA 2514–2517.Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1990

Authors and Affiliations

  • F. A. Beland
  • F. F. Kadlubar

There are no affiliations available

Personalised recommendations